biotech / news / / Devdiscourse
Bristol Myers Squibb surpassed Wall Street expectations in the first quarter.
Bristol Myers Squibb's Q1 adjusted earnings were $1.58 per share, exceeding Wall Street forecasts.
KEY POINTS
- Eliquis sales rose 16% year-over-year to $4.14 billion, surpassing 75% new prescription share.
- The company's total quarterly revenue hit $11.49 billion, beating analysts' expectations of $10.9 billion.
- Bristol Myers' growth segment increased 12% to $6.23 billion, now over half of total revenue.
COMPANIES
Summarized by Newsio from Devdiscourse. How we summarize →